The tax dispute of PT JMPR highlights the vulnerability of the healthcare sector to VAT interpretations regarding support services and technical procedures for input tax credits. The core conflict lies in the classification of management and pharmaceutical services as part of medical services exempted from VAT under Article 4A paragraph (3) of the Indonesian VAT Law (UU PPN). In this decision, the Panel of Judges draws a sharp line between direct medical actions and administrative transactions between legal entities.
The conflict arose when the Directorate General of Taxes (DJP) issued a positive correction to the VAT Base (DPP) from transactions claimed by PT JMPR as medical health services. The DJP argued that billings for equipment calibration, medical waste management, and outpatient medicine sales are taxable deliveries as they do not meet the criteria of medical services provided directly to patients. Conversely, the Input Tax dispute occurred due to differing recalculation methods and timelines.
The Panel of Judges provided a balanced yet firm resolution. Regarding the VAT Base, the Panel upheld the DJP's correction, considering that management and operational services billed to other companies are legally not medical services. However, regarding the Input Tax correction, the Panel ruled in favor of PT JMPR. The Panel deemed the DJP's recalculation outside the period specified by PMK-135/PMK.011/2014 (which is the March tax period of the following year) as procedurally flawed.
The implications of this decision confirm that healthcare sector Taxpayers cannot automatically assume all activities are VAT-exempt. Precise contract separation between medical and non-medical services is essential. A crucial conclusion for tax practitioners is that compliance with administrative regulations such as PMK 135/2014 is absolute; procedural errors by the DJP in determining the timing of corrections can invalidate the substance of the correction itself.